We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Smart Pills Market Worth USD 3 Billion by 2025

By HospiMedica International staff writers
Posted on 16 Jan 2018
The global smart pills market was valued at USD 779.4 million in 2016 and is expected to grow at a CAGR of 15.5% during the forecast period (2017-2025) to reach USD 3.0 billion by 2025, driven by the increased prevalence of colorectal cancer and gastrointestinal disorders, geographical expansion by the major players, rising cancer screening awareness programs and faster FDA approvals.

These are the latest findings of Grand View Research, Inc. More...
(San Francisco, CA, USA), a market research and consulting company.

The geriatric population, immobile patients, and patients with paralysis are the major consumers of smart pills. Smart pills are used mainly for screening and treatment of diseases, such as colorectal cancer, gastroparesis, gastric ulcers, and gastroesophageal disorders. As a result, capsule endoscopy is expected to be the largest application segment of the global smart pills market due to the increase in cancer screening awareness programs, rising incidence of Crohn's disease and bowel cancer, and higher demand for minimally invasive procedures. Capsule endoscopy is expected to replace traditional endoscopy methods due to its advantages, such as ease of administration and detailed observation of the gastrointestinal tract.

Regionally, North America dominates the global smart pills market with the largest revenue share of 57.1% in 2016 due to the wide availability of products, favorable reimbursement policies, rise in government healthcare investments, and increase in healthcare expenditure in the region. However, Asia Pacific is expected to be the world’s fastest-growing market for smart pills during the forecast period, led by a rise in disposable income, mandatory healthcare insurance, and increased healthcare expenditure in the region. Japan, China, and India are expected to be the key markets for smart pills in the Asia Pacific region.

Being a new technology, there have been limited product approvals so far and even fewer products are commercially available. However, the market players are studying a large number of smart pills for their potential use in diagnosis and in therapeutics of various chronic and acute diseases. The smart pills market is dominated by a limited number of players. The established players in the smart pills market are expanding their portfolio by upgrading their existing devices, whereas the new players are focusing on capturing the market in the emerging economies by launching breakthrough products, such as video endoscopy capsules, at affordable prices.

Related Links:
Grand View Research


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Gas Analyzer
GE SAM
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie MellonImage: Tubes attached to this artificial lung are connected to the patient\'s neck or chest, allowing blood to circulate and get oxygen while the patient is conscious. (Image Credit: Carnegie Mellon University)University)

Portable Artificial Lung Technology Could Reshape Care for Chronic Lung Disease

Chronic lung disease can leave patients dependent on prolonged mechanical ventilation or awaiting transplantation, both of which carry substantial morbidity and healthcare costs. Ventilatory support may... Read more

Surgical Techniques

view channel
Image Credit: 123RF

Needle-Free Intrauterine Anesthesia Technique Reduces Pain During IUD Insertion

Pain during intrauterine device (IUD) placement often deters women from choosing this long-acting contraception. Avoiding or undertreating procedural pain can reduce uptake and satisfaction with effective... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.